Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients.

Korean J Hematol · 2011 · PMC3065622 · PMID 21461300

Europe PMC DOI

hedged sentence

0.2290

closest p · 4.6× alpha

0.2290

boldest claim

The sentences

showed a trendP =0.229not close (p > 0.1)

The high-risk group showed a trend to a lower 3-year LFS (60.0% vs. 77.1% vs. 92.9%; P =0.229) than the intermediate- and low-risk groups ( Fig. 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.